Revolution Medicines Inc (RVMD : NASDAQ)
Common Stock
$199.70
USD
+5.47 (2.82%)
Last updated: 2026-11-04
Follow RVMD
RVMD
Revolution Medicines Inc
WealthAwesomePerformance
1 Day
+2.82%
1 Week
+5.82%
1 Month
-3.84%
YTD
+152.72%
Key Statistics
Market Cap
$42.80B
52W High
$224.31
52W Low
$58.91
P/E Ratio
-
50 Day MA
$198.45
200 Day MA
$156.73
Beta
1.43
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/4/2026 | $198.50 | $201.79 | $192.34 | $199.70 | $199.70 | 2,550,351 |
| 11/3/2026 | $188.63 | $197.00 | $188.63 | $194.23 | $194.23 | 1,385,807 |
| 11/2/2026 | $190.71 | $192.98 | $187.12 | $188.17 | $188.17 | 1,367,721 |
| 10/30/2026 | $188.38 | $192.75 | $187.28 | $191.31 | $191.31 | 1,099,300 |
| 10/29/2026 | $187.38 | $192.00 | $187.37 | $190.27 | $190.27 | 1,322,561 |
| 10/28/2026 | $185.08 | $188.85 | $183.85 | $188.72 | $188.72 | 888,459 |
| 10/27/2026 | $182.68 | $187.66 | $181.20 | $186.22 | $186.22 | 1,171,518 |
| 10/26/2026 | $186.99 | $188.30 | $181.00 | $183.90 | $183.90 | 1,659,368 |
| 10/23/2026 | $187.59 | $189.52 | $183.61 | $186.99 | $186.99 | 1,721,800 |
| 10/22/2026 | $192.06 | $194.59 | $185.34 | $187.69 | $187.69 | 1,485,567 |
Analyst Price Targets
Based on 25 analysts covering RVMD · as of Oct 26, 2026
Wall Street analysts forecast RVMD stock price to rise 29.6% over the next 12 months.
Consensus
Strong Buy4.72 / 5.00
Avg. Target
US$258.84
+29.6% Upside
Previously US$257.53 on Oct 22, 2026
Current Price
US$199.70
Last close
Analyst Breakdown (25 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on RVMD's historical volatility
30-Day Vol
47.4%
Annualized
90-Day Vol
39.5%
Annualized
Trend (90d)
-12.1%
Annualized drift
90d Mean
US$191.24
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$196.84 | US$167.15 – US$231.80 |
| 60 trading days | US$194.02 | US$153.96 – US$244.49 |
| 90 trading days | US$191.24 | US$144.07 – US$253.84 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Revolution Medicines Inc
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Financials
- Revenue (TTM)
- $742,000
- EBITDA
- $-1.62B
- Profit Margin
- 0.00%
- ROE (TTM)
- -79.09%
- EPS (Diluted)
- -9.12
- Book Value
- 12.16
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About RVMD.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| INM | InMed Pharmaceuticals Inc | $17.50 | +941.67% |
| OMH | Ohmyhome Limited Ordinary Shares | $15.55 | +432.53% |
| CRIS | Curis Inc | $1.11 | +56.34% |
| PMAX | Powell Max Limited Class A Ordinary Shares | $1.04 | +54.07% |
| RFAIR | RF Acquisition Corp II Right | $0.24 | +50.00% |
| CRCT | Cricut Inc | $8.88 | +48.74% |
| LYEL | Lyell Immunopharma Inc | $15.43 | +43.27% |
| GENVR | Gen Digital Inc. Contingent Value Rights | $4.03 | +42.40% |
RVMD.US news timeline
5 articles covering RVMD.US, most recent first
Latest